We Offer Worldwide Shipping
Login Wishlist

3,5,3′-Trihydroxybibenzyl

$928

  • Brand : BIOFRON

  • Catalogue Number : BN-O0963

  • Specification : 96%(HPLC)

  • CAS number : 86630-23-1

  • Formula : C14H14O3

  • Molecular Weight : 230.26

  • PUBCHEM ID : 21574990

  • Volume : 5mg

Available on backorder

Quantity
Checkout Bulk Order?

Catalogue Number

BN-O0963

Analysis Method

HPLC,NMR,MS

Specification

96%(HPLC)

Storage

2-8°C

Molecular Weight

230.26

Appearance

Powder

Botanical Source

Structure Type

Phenols

Category

Standards;Natural Pytochemical;API

SMILES

C1=CC(=CC(=C1)O)CCC2=CC(=CC(=C2)O)O

Synonyms

3,3',5-Trihydroxybibenzyl/1,3-Benzenediol,5-[2-(3-hydroxyphenyl)ethyl]

IUPAC Name

5-[2-(3-hydroxyphenyl)ethyl]benzene-1,3-diol

Density

Solubility

Soluble in Chloroform,Dichloromethane,Ethyl Acetate,DMSO,Acetone,etc.

Flash Point

Boiling Point

Melting Point

InChl

InChI=1S/C14H14O3/c15-12-3-1-2-10(6-12)4-5-11-7-13(16)9-14(17)8-11/h1-3,6-9,15-17H,4-5H2

InChl Key

UMZJVKFVOMTAFO-UHFFFAOYSA-N

WGK Germany

RID/ADR

HS Code Reference

2933990000

Personal Projective Equipment

Correct Usage

For Reference Standard and R&D, Not for Human Use Directly.

Meta Tag

provides coniferyl ferulate(CAS#:86630-23-1) MSDS, density, melting point, boiling point, structure, formula, molecular weight etc. Articles of coniferyl ferulate are included as well.>> amp version: coniferyl ferulate

No Technical Documents Available For This Product.

PMID

27880930

Abstract

Purpose
Lactate dehydrogenase (LDH), which was an indirect marker of hypoxia, was a potentially prognostic factor in several malignancies. There is a lack of evidence about the prognostic value of serum LDH level in patients with hepatocellular carcinoma (HCC) receiving sorafenib treatment from hepatitis B virus endemic areas.

Materials and Methods
A total of 119 HBV-related HCC patients treated by sorafenib from a Chinese center were included into the study. They were categorized into 2 groups according to the cut-off value of pre-treatment LDH, which was determined by the time dependent receiver operating characteristics (ROC) curve for the overall survival. The prognostic value of LDH was evaluated. The relationships between LDH and other clinicopathological factors were also assessed.

Results
The cut-off value was 221 U/L. With a median follow up of 15 (range, 3-73) months, 91 patients reached the endpoint. Multivariate analysis proved that pre-treatment serum LDH level was an independent prognostic factor for both overall survival (OS) and progression-free survival (PFS). For patients whose pre-treatment LDH ≥ 221 U/L, increased LDH value after 3 months of sorafenib treatment predicted inferior OS and PFS. And patients with elevated pre-treatment LDH level predisposed to be featured with lower serum albumin, presence of macroscopic vascular invasion, advanced Child-Pugh class, advanced T category, higher AFP, and higher serum total bilirubin.

Conclusions
Serum LDH level was a potentially prognostic factor in HCC patients treated by sorafenib in HBV endemic area. More relevant studies with reasonable study design are needed to further strengthen its prognostic value.

KEYWORDS

LDH, hepatocellular carcinoma, sorafenib, prognosis, HBV endemic area

Title

Lactate dehydrogenase is a prognostic indicator in patients with hepatocellular carcinoma treated by sorafenib: results from the real life practice in HBV endemic area

Author

Mu-xing Li,1 Hong Zhao,1 Xin-yu Bi,1 Zhi-yu Li,1 Xue-song Yao,2 Huai Li,2 Zhen Huang,1 Yue Han,2 Jian-guo Zhou,1 Jian-jun Zhao,1 Ye-fan Zhang,1 Dong-bin Zhao,1 and Jian-qiang Cai1

Publish date

2016 Dec 27;

PMID

21118608

Abstract

Objective
The evolutionary history of human malaria parasites (genus Plasmodium) has long been a subject of speculation and controversy. The complete genome sequences of the two most widespread human malaria parasites, P. falciparum and P. vivax, and of the monkey parasite P. knowlesi are now available, together with the draft genomes of the chimpanzee parasite P. reichenowi, three rodent parasites, P. yoelii yoelli, P. berghei and P. chabaudi chabaudi, and one avian parasite, P. gallinaceum.

Methods
We present here an analysis of 45 orthologous gene sequences across the eight species that resolves the relationships of major Plasmodium lineages, and provides the first comprehensive dating of the age of those groups.

Results
Our analyses support the hypothesis that the last common ancestor of P. falciparum and the chimpanzee parasite P. reichenowi occurred around the time of the human-chimpanzee divergence. P. falciparum infections of African apes are most likely derived from humans and not the other way around. On the other hand, P. vivax, split from the monkey parasite P. knowlesi in the much more distant past, during the time that encompasses the separation of the Great Apes and Old World Monkeys.

Conclusion
The results support an ancient association between malaria parasites and their primate hosts, including humans.

Title

Genome sequences reveal divergence times of malaria parasite lineages

Author

JOANA C. SILVA,1,2 AMY EGAN,2 ROBERT FRIEDMAN,3 JAMES B. MUNRO,1,2 JANE M. CARLTON,4 and AUSTIN L. HUGHES3,*

Publish date

2011 Nov 1;

PMID

31637003

Abstract

The discrepancy of indoleamine 2, 3-dioxygenase 1 (IDO1) function in atherosclerosis has been noted. Compared to the protective effect of IDO1 against established atherogenesis, the role of IDO1 in the developmental process of atherosclerosis is still unclear. Here, the expression patterns and activities of IDO1 and its isoenzyme tryptophan 2,3-dioxygenase (TDO) in aortas and blood samples of patients with atherosclerosis were investigated. IDO1 and TDO were colocalized with CD3-positive lymphocytes and CD68-positive macrophages in atherosclerotic lesions. The expression and activity of IDO1 and TDO increased with the grade of the histological classification in early atherosclerosis (grade I, II), but the increase did not continue in advanced atherosclerosis (grade III). Treatment of THP-1 macrophages (THP-M) with oxidized low-density lipoprotein (oxLDL) induced the expression of IDO1 via the PI3K/Akt/NF-κB pathway, indicating the potential function of IDO1 in foam cells. Before and after treatment with oxLDL on THP-M, IFN-γ-induced IDO1 exhibited different degrees of promotion on foaming, inflammatory factor production and cell apoptosis. Finally, we found that the IDO1 inhibitor 1-methyl-tryptophan could elevate the high-density lipoprotein cholesterol level in serum and reduce the area of the aortic atherosclerotic lesions in high-fat diet-fed ApoE−/− mice. Our study indicated that IDO1 played a complicated and unfixed role in the entire process of atherogenesis, despite the atheroprotective role in established atherosclerosis. IDO1 also had proatherosclerotic functions in the developmental stages of atherosclerosis. Modulation of IDO1 could be a good method for alleviating atherosclerosis.

Subject terms: Cardiology, Molecular biology

Title

The proatherosclerotic function of indoleamine 2, 3-dioxygenase 1 in the developmental stage of atherosclerosis

Author

Heng Liang,#1 Mantian Chen,#2 Fangfei Qi,#1 Lei Shi,1 Zhenzhen Duan,1 Ruoyu Yang,1 Jinchao He,1 Bin Lou,3 Yigang Li,corresponding author2 and Qing Yangcorresponding author1

Publish date

2019;


Description :

Empty ...